These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11192820)

  • 21. Mifepristone and misoprostol for early abortion.
    JNMA J Nepal Med Assoc; 2006; 45(161):I. PubMed ID: 17160090
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antiprogestin to clinical use].
    Heikinheimo O
    Duodecim; 2000; 116(12):1261-2. PubMed ID: 11988960
    [No Abstract]   [Full Text] [Related]  

  • 23. Fear of black market means no RU-486 for Canada until US approves drug.
    Sibbald B
    CMAJ; 1999 Jun; 160(12):1753-4. PubMed ID: 10410644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in progesterone-induced-blocking-factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks.
    Salomon LJ; Rozenberg P; Szekeres-Bartho J; Malagrida L; Giudicelli Y; Ville Y
    J Matern Fetal Neonatal Med; 2005 May; 17(5):353-6. PubMed ID: 16147850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early termination of pregnancy with pharmacological means].
    Honkanen H; von Hertzen H
    Duodecim; 2000; 116(12):1277-82; quiz 1283, 1308. PubMed ID: 11988962
    [No Abstract]   [Full Text] [Related]  

  • 26. Update on medication abortion.
    Beal MW
    J Midwifery Womens Health; 2007; 52(1):23-30. PubMed ID: 17207747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombotic thrombocytopenic purpura secondary to mifepristone in a patient of medical termination in early pregnancy.
    Chung LW; Yeh SP; Hsieh CY; Chiu CF
    Ann Hematol; 2007 May; 86(5):385-6. PubMed ID: 17180387
    [No Abstract]   [Full Text] [Related]  

  • 28. Happy anniversary mifepristone: a decade of promise and challenges.
    Jordan B; Shields WC
    Contraception; 2010 Sep; 82(3):219-20. PubMed ID: 20705148
    [No Abstract]   [Full Text] [Related]  

  • 29. Mifepristone--controversy, beliefs, and politics--issues for everyone.
    Hussar DA
    Ann Pharmacother; 2001 Mar; 35(3):373-5. PubMed ID: 11261538
    [No Abstract]   [Full Text] [Related]  

  • 30. Fatal infections associated with mifepristone-induced abortion.
    Greene MF
    N Engl J Med; 2005 Dec; 353(22):2317-8. PubMed ID: 16319378
    [No Abstract]   [Full Text] [Related]  

  • 31. Failed medical termination of twin pregnancy with mifepristone: a case report.
    Hausknecht R
    Contraception; 2006 Jan; 73(1):109; author reply 109-10. PubMed ID: 16371308
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study of histopathology of endometrium following termination of early pregnancy using mifepristone].
    Qiu X; Li D; Zhou X
    Zhonghua Fu Chan Ke Za Zhi; 1999 May; 34(5):272-4. PubMed ID: 11326931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mifepristone and prostaglandin for termination of pregnancy: contraindications for use, reasons and rationale.
    Davey A
    Contraception; 2006 Jul; 74(1):16-20. PubMed ID: 16781254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Termination of early pregnancy with antiprogestin and prostaglandin].
    Bygdeman M; Swahn ML
    Lakartidningen; 1988 Nov; 85(47):4040-1. PubMed ID: 3200009
    [No Abstract]   [Full Text] [Related]  

  • 35. Mifepristone in abortion care.
    Schreiber C; Creinin M
    Semin Reprod Med; 2005 Feb; 23(1):82-91. PubMed ID: 15714392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion.
    Liao AH; Han XJ; Wu SY; Xiao DZh; Xiong CL; Wu XR
    Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):211-6. PubMed ID: 15358467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mifepristone label laws and trends in use: recent experiences in four US states.
    Sheldon WR; Winikoff B
    Contraception; 2015 Sep; 92(3):182-5. PubMed ID: 26116033
    [No Abstract]   [Full Text] [Related]  

  • 38. Current medical abortion care.
    Creinin MD
    Curr Womens Health Rep; 2003 Dec; 3(6):461-9. PubMed ID: 14613667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. When Off-label is Illegal: Implications of Mandating the FDA-approved Protocol for Mifepristone-induced Abortions.
    Britton L; Bryant A
    Womens Health Issues; 2015; 25(5):433-5. PubMed ID: 26169217
    [No Abstract]   [Full Text] [Related]  

  • 40. The mifepristone-misoprostol regimen for early medical abortion.
    Ellertson C; Waldman SN
    Curr Womens Health Rep; 2001 Dec; 1(3):184-90. PubMed ID: 12112968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.